Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

British Journal of Haematology

Volumn 82, Issue 2, 1992, Pages 460-466

  Agarwal, M B ^a   Gupte, S S ^b   Viswanathan, C ^a   Vasandani, D ^b   Ramanathan, J ^a   Desai, Neena ^c   Puniyani, R R ^d   Chhablani, A T ^e  

^a LTMG Medical College and Hospital   (India)

^b JJ Group of Hospitals ^*  (India)

^c BOMBAY HOSPITAL   (India)

^d Department of Mechanical Engineering   (India)

^e Immunopathology and Haematology Diagnostic Centre ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; CHILD; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; IRON CHELATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CASE REPORT; CHILD; DEFEROXAMINE; HUMAN; IRON; IRON CHELATING AGENTS; JOINTS; PAIN; PYRIDONES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026668939     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1992.tb06445.x     Document Type: Article

References (17)

1. 1) an oral iron chelator in patients of beta thalassemia major with iron overload
2. 1
3. 1): clinical observations
4. The development of new iron chelating drugs (ii)
5. Agranulocytosis and thrombocyto‐penia in patients with Blackfan‐Diamond anaemia during oral chelation trial
6. 1 I
7. 1–2‐Dimethyl‐3‐hydroxypyrid‐4‐one, an orally active chelator for treatment of iron overload
8. 1 I and other alpha ketohydrox‐ypyridines
9. 1). I. Iron chelation and metabolic studies
10. 1 induced systemic lupus erythematosis
11. 1 and desferrioxamine in patients loaded with iron
12. 1 in patients with thalassemia major. Iron balance and dose response studies
13. 1 (1–2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with β thalassaemia major
14. 1 in rheumatoid arthritis